Entry requirements

120 credits with 60 credits in chemistry including Biomaterials II; or 180 credits in biology, pharmaceutical chemistry or medical science including Regenerative Medicine, 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.

Learning outcomes

On completion of the course, the student should be able to:

• explain the design principles of nanomaterials for drug delivery applications and describe the effect of such nanomaterials on cells and tissues in vivo.
• explain different strategies for modifying cells and scaffolds for biomedical applications.
• describe and discuss the costs and benefits of different bioengineered products (e.g. wearable devices, diagnostic tools, prosthesis etc.) that are used in clinical applications.
• discuss the challenges in translational research with specific focus on addressing clinical problems through laboratory research, clinical testing and development of new medical products.

Content

Principles of 3D scaffold design and 3D printing of living cells. Nanoformulations for drug delivery, pharmacokinetics and pharmacodynamics. Different aspects of biomedical products and their regulations. Regenerative medicine and tissue engineering. The course also includes critical evaluation of scientific material, scientific writing and presentation skills.

Instruction

Lectures and seminars.

Assessment

Written examination at the end of the course represents (2.5 credits). Assignment represents (2.5 credits). The final grade corresponds to a weighted average of the written examination and the assignment.

If there are special reasons for doing so, an examiner may make an exception from the method of assessment indicated and allow a student to be assessed by another method. An example of special reasons might be a certificate regarding special pedagogical support from the disability coordinator of the university.